Osterweis Capital Management Inc. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 67,599 shares of the semiconductor company’s stock, valued at approximately $30,154,000. Synopsys comprises 1.4% of Osterweis Capital Management Inc.’s portfolio, making the stock its 28th biggest holding.
A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Synopsys by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock valued at $8,673,315,000 after buying an additional 283,677 shares during the period. BlackRock Inc. acquired a new position in Synopsys during the 2nd quarter worth about $7,228,099,000. State Street Corp boosted its holdings in Synopsys by 0.3% during the 4th quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock valued at $4,128,317,000 after acquiring an additional 28,532 shares during the period. Morgan Stanley boosted its holdings in Synopsys by 2.5% during the 4th quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock valued at $2,148,491,000 after acquiring an additional 109,917 shares during the period. Finally, Geode Capital Management LLC grew its position in Synopsys by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock valued at $2,017,256,000 after acquiring an additional 54,329 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on SNPS. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. BNP Paribas Exane raised their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Piper Sandler raised Synopsys from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $563.59.
Insider Activity
In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Synopsys Stock Down 0.8%
Shares of NASDAQ:SNPS opened at $394.51 on Tuesday. The firm has a 50 day simple moving average of $418.53 and a 200-day simple moving average of $439.92. Synopsys, Inc. has a twelve month low of $366.00 and a twelve month high of $615.79. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $75.54 billion, a PE ratio of 91.32, a P/E/G ratio of 2.34 and a beta of 1.23.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period last year, the firm posted $3.67 EPS. The company’s revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
